# Rubius Therapeutics
 (stock symbol: RUBY) Logo in transparent PNG format

## Rubius Therapeutics
 Logo large

### Rubius Therapeutics
 Logo large Download PNG (36.95 KB)

![Rubius Therapeutics
 Logo large Download PNG (36.95 KB)](/img/orig/RUBY_BIG-fe11280b.png)

## Rubius Therapeutics
 Logo icon format

### Rubius Therapeutics
 Logo icon format Download PNG (92.58 KB)

![Rubius Therapeutics
 Logo icon format Download PNG (92.58 KB)](/img/orig/RUBY-d137bb11.png)

## About Rubius Therapeutics


Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatment of HPV-positive tumors; and RTX-T1D for treating type 1 diabetes. The company was incorporated in 2013 and is headquartered in Cambridge, Massachusetts.

1. Website domain: rubiustx.com
2. Employees: 213
3. Marketcap: $2.21 Million USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
